A 5 Day Course of Fludarabine and Cytarabine Followed by Full Intensity Allogeneic Stem Cell Transplantation (FA5-Bucy) in Treating Patients With High-risk, Recurrent or Refractory Acute Leukemia and Advanced Myelodysplastic Syndrome

Clinical trial NCT02328950 · UNKNOWN

Trial details

NCT number: NCT02328950
Sponsor: Fujian Medical University
Status: UNKNOWN
Study type: OBSERVATIONAL

Myelodysplastic Syndromes Leukemia, Myeloid, Acute Precursor Cell Lymphoblastic Leukemia-Lymphoma

Start date: 2014-12-01
Primary completion: 2016-09-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.